QIAGEN N.V. Income (Loss) from Equity Method Investments
QIAGEN N.V. (QGEN) reported Income (Loss) from Equity Method Investments of $4.40 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-20.
Financial Statements › Income Statement › Other Income
us-gaap:IncomeLossFromEquityMethodInvestments · last filed 2026-03-20
| Period end | Income (Loss) from Equity Method Investments 12 month | Income (Loss) from Equity Method Investments 12 month as first filed |
|---|---|---|
| 2025-12-31 | $4.40M 20-F · filed 2026-03-20 | |
| 2024-12-31 | $5.72M 20-F · filed 2026-03-20 | |
| 2023-12-31 | $4.16M 20-F · filed 2026-03-20 | |
| 2022-12-31 | $3.76M 20-F · filed 2025-03-31 | |
| 2021-12-31 | $11.99M 20-F · filed 2024-03-11 | |
| 2020-12-31 | $5.02M 20-F · filed 2023-03-13 | |
| 2019-12-31 | $2.08M 20-F · filed 2022-03-14 | |
| 2018-12-31 | $2.59M 20-F · filed 2021-03-05 | |
| 2017-12-31 | $3.16M 20-F · filed 2020-03-02 | |
| 2016-12-31 | $2.82M 20-F · filed 2019-03-06 | |
| 2015-12-31 | $661.00K 20-F · filed 2018-03-06 | |
| 2014-12-31 | $3.48M 20-F · filed 2017-03-06 | $3.46M 20-F · filed 2015-03-02 |
| 2013-12-31 | $1.75M 20-F · filed 2016-02-29 | |
| 2012-12-31 | $1.85M 20-F · filed 2015-03-02 |